Demis Hassabis, chief of Google DeepMind, believes there's a 50% chance of achieving AGI within 5 years. AGI means ...

AI-powered drug company spun out of Google’s DeepMind says human trials are ‘very close’ After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials.

Among new hires, former Google Gemini engineering lead Amar Subramanya joined Microsoft AI as corporate vice-president.

Google DeepMind’s spin-off Isomorphic Labs says it’s almost ready to begin human testing for AI-designed drugs. Built on the success of AlphaFold, the company aims to speed up drug development in ...

Google DeepMind CEO Demis Hassabis heads Gemini and the company's AI push while gaining more power. Here's how he became ...

MSFT Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI.

Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. ... We develop those, put them into human clinical trials… we haven’t got that yet, ...

Researchers are urging developers to prioritize research into “chain-of-thought” processes, which provide a window into how ...

Google has announced the consolidation of its formerly separate AI research labs — Google Brain and DeepMind — into a new unit named Google DeepMind. The new team will spearhead groundbreaking ...